LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,118,081 | -16.9% | 135,482 | 0.0% | 0.17% | -12.5% |
| Q2 2023 | $9,768,252 | -2.0% | 135,482 | 0.0% | 0.19% | -3.5% |
| Q1 2023 | $9,966,056 | +39.8% | 135,482 | +26.9% | 0.20% | +38.2% |
| Q4 2022 | $7,131,034 | -34.1% | 106,752 | -15.1% | 0.14% | -37.9% |
| Q3 2022 | $10,823,000 | -45.0% | 125,692 | -43.0% | 0.23% | -41.0% |
| Q2 2022 | $19,666,000 | -42.4% | 220,422 | -27.4% | 0.39% | -30.2% |
| Q1 2022 | $34,132,000 | -27.2% | 303,422 | 0.0% | 0.56% | -19.5% |
| Q4 2021 | $46,867,000 | +10.9% | 303,422 | 0.0% | 0.70% | +7.7% |
| Q3 2021 | $42,273,000 | -4.2% | 303,422 | -9.7% | 0.65% | -2.1% |
| Q2 2021 | $44,106,000 | -28.5% | 336,197 | -16.9% | 0.66% | -33.0% |
| Q1 2021 | $61,708,000 | +40.6% | 404,775 | -8.3% | 0.99% | +33.1% |
| Q4 2020 | $43,876,000 | +14.2% | 441,190 | +9.4% | 0.74% | -1.3% |
| Q3 2020 | $38,428,000 | -3.9% | 403,150 | +12.7% | 0.75% | -6.6% |
| Q2 2020 | $39,995,000 | +292.3% | 357,580 | +155.1% | 0.81% | +233.1% |
| Q1 2020 | $10,194,000 | -8.0% | 140,175 | +31.9% | 0.24% | +23.5% |
| Q4 2019 | $11,086,000 | -5.4% | 106,295 | -9.7% | 0.20% | -8.0% |
| Q3 2019 | $11,722,000 | -7.3% | 117,763 | +6.3% | 0.21% | -4.5% |
| Q2 2019 | $12,644,000 | -12.9% | 110,763 | -4.1% | 0.22% | -14.6% |
| Q1 2019 | $14,514,000 | +15.3% | 115,453 | +24.5% | 0.26% | +3.6% |
| Q4 2018 | $12,589,000 | -29.3% | 92,769 | +43.1% | 0.25% | -11.0% |
| Q3 2018 | $17,796,000 | +15.7% | 64,832 | -12.7% | 0.28% | +9.7% |
| Q2 2018 | $15,379,000 | +23.8% | 74,232 | -1.3% | 0.26% | +21.1% |
| Q1 2018 | $12,424,000 | -3.9% | 75,225 | -20.3% | 0.21% | -3.2% |
| Q4 2017 | $12,924,000 | -3.8% | 94,385 | -4.3% | 0.22% | -6.0% |
| Q3 2017 | $13,435,000 | -4.2% | 98,675 | -14.6% | 0.23% | -4.5% |
| Q2 2017 | $14,022,000 | +110.1% | 115,505 | +83.2% | 0.24% | +105.9% |
| Q1 2017 | $6,675,000 | +5.0% | 63,065 | +0.8% | 0.12% | 0.0% |
| Q4 2016 | $6,356,000 | -8.2% | 62,555 | -7.8% | 0.12% | -4.0% |
| Q3 2016 | $6,926,000 | – | 67,860 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |